Research use onlyNot for human or veterinary use
ENCORE BIO LABSRESEARCH COLLECTION
Wolverine Stack — complete Encore Bio Labs reference vialMATERIAL / 24

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

Wolverine Stack

Two peptides. Two scientific stories to explore. Wolverine brings together BPC-157 + TB-500. BPC-157 draws interest through studies of tendon-cell movement and survival; TB-500 through research into its relationship with thymosin-beta-4 fragments. Discover the science behind each component of this pairing.

Components
BPC-157 / TB-500

Formats & reference pricing

USD
Listed formatReference price
BPC-157 + TB-500 vial$95 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

Separate components behind a blend name

Wolverine Stack is the catalog name for a BPC-157 and TB-500 combination. BPC-157 has a 15-residue reference sequence. A 2012 analytical paper identified a seven-residue, acetylated thymosin beta4 fragment in a TB-500 sample. That sample-specific finding cannot establish which TB-500 form is in this blend.

Catalog component names
BPC-157 + TB-500
BPC-157 reference
15 residues; exact TB-500 form pending

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
Wolverine Stack
Components
BPC-157 / TB-500
Listed formats
BPC-157 + TB-500 vial
Reference price range
$95 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Regulatory context

Regulatory & safety notes.

FDA’s public compounding materials can provide regulatory safety context. They do not verify a current Encore Bio Labs lot.

FDA PUBLIC RECORD · REVIEWED OCT 2026BPC-157 + TB-500

FDA compounding record · BPC-157 + TB-500

FDA describes potential immunogenicity and characterization concerns for BPC-157 and separately for thymosin beta-4 fragment (TB-500). FDA notes limited or absent human safety information for relevant proposed uses. The combination itself is not represented here as FDA-evaluated or approved.

Separate component-level FDA records do not verify the composition, quantity, purity, sterility, potency, or suitability of this blend.

FDA record type
Human drug compounding safety context
Human-use guidance
Not provided

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for Wolverine Stack in this catalog.

Encore documentary summary · not a laboratory-issued COA

Report availability
2 related reports located
Formats & scope
Two blend reports are potential references only; they use different component descriptions and molecular forms.
Report authenticity
Laboratory authentication pending
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Resolve finished-blend composition and component amounts. Separate-component testing does not certify the finished blend; differently defined blends are not interchangeable.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Report review pending

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

Copy preparation
2 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
Release review pending. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
No website copy released. No download is available for this product.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

Select individual reports for release after reviewing remaining privacy exposure, sample scope and discrepancies. A prepared review packet is not a cleared public copy.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which Wolverine Stack formats and reference prices are listed?

BPC-157 + TB-500 vial: $95 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the Wolverine Stack reports?

Report review pending. The Documentation section on this page lists the reviewed source status and outstanding items for this material. No public PDF is available for this product; an unreleased or missing document is not a certificate of current inventory.

03Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

04How should research suitability be assessed?

Qualified personnel should evaluate material identity, lot-specific records, institutional requirements, and study design. Report review pending. Independent inventory review remains pending, and no product-specific SDS was located in the reviewed set. This catalog provides no personal-use or preparation guidance.